Pasi, K., Rangarajan, S., Georgiev, P., et al. Targeting of antithrombin in hemophilia A or B with RNAi therapy. Boston: 2017 819-828,.
Pasi, K., Rangarajan, S., Georgiev, P., et al. Targeting of antithrombin in hemophilia A or B with RNAi therapy. Boston: 2017 819-828,.
Pasi, K., Rangarajan, S., Georgiev, P., et al. (2017) Targeting of antithrombin in hemophilia A or B with RNAi therapy, Boston: 819-828,.
Pasi, K., Rangarajan, S., Georgiev, P., & et al. (2017). Targeting of antithrombin in hemophilia A or B with RNAi therapy. New England Journal of Medicine, The, 377 (9), 819-828.
Pasi K, Rangarajan S, Georgiev P, et A. Targeting of antithrombin in hemophilia A or B with RNAi therapy. New England Journal of Medicine, The. 2017; 377(9): 819-828.
🍪 Използваме "бисквитки", за да осигурим най-доброто изживяване на нашия уебсайт. Научете повече в нашата Политика за поверителност.
